Hong Jun Liang
Direktor/Vorstandsmitglied bei BEIJING STRONG BIOTECHNOLOGIES,INC.
Aktive Positionen von Hong Jun Liang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Direktor/Vorstandsmitglied | 13.08.2020 | - |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Direktor/Vorstandsmitglied | 15.09.2020 | - |
Karriereverlauf von Hong Jun Liang
Ehemalige bekannte Positionen von Hong Jun Liang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Direktor/Vorstandsmitglied | 13.11.2018 | 01.01.2020 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Vorsitzender | - | 15.11.2019 |
Statistik
International
| China | 5 |
Operativ
| Director/Board Member | 3 |
| Chairman | 1 |
Sektoral
| Health Technology | 4 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Börse
- Insiders
- Hong Jun Liang
- Erfahrung